stock pickSLDBemail_stock_pick
SLDB: $240M Placement Sparks New Growth Potential!
# SLDB: $240 M Placement Sparks New Growth Potential! ## Company & Placement Overview Solid Biosciences Inc.
Read moreFeatured By
Research
In-depth company research, stock analysis, and market opportunities from the Smart Investors Daily research team.
# SLDB: $240 M Placement Sparks New Growth Potential! ## Company & Placement Overview Solid Biosciences Inc.
Read more# IOVA Stock Surges on Analyst Upgrades—Don’t Miss Out! **Overview:** Iovance Biotherapeutics (NASDAQ: **IOVA**) has recently seen its stock price spike after a series of bullish…
Read more# PCRX: Inducement Grants Could Spark Major Growth! ## Company Overview & Recent Developments Pacira BioSciences (NASDAQ: PCRX) is a specialty pharmaceutical company focused on…
Read more# EOSE Class Action Alert: Investors Must Act Now!
Read more# Company Overview and ONS-5010 Background **Outlook Therapeutics (NASDAQ: OTLK)** is a clinical-stage biopharma focused on ophthalmic diseases, with its lead candidate…
Read more# PCRX: Inducement Grants Spark Major Growth Potential! ## Introduction Pacira BioSciences, Inc. (NASDAQ: **PCRX**) is a specialty pharmaceutical company focused on non-opioid…
Read more**Introduction** A looming wave of commercial real estate (CRE) debt is nearing maturity, raising concern across markets. The Mortgage Bankers Association reports that **$875…
Read more# MREO: Act Now!
Read more# Bank of America Boosts MRVL Stock Price for 2026!
Read more# Act Now: BSX Investors Urged to Secure Counsel Before Deadline!
Read more# CR: New Insights on Cardiac Rehab Could Boost Growth!
Read more# TNGX Soars 36%: Strong Q4 Results Fueling Momentum! ## Company Overview and Q4 Surge Tango Therapeutics (NASDAQ: **TNGX**) is a clinical-stage biotech focused on **precision…
Read more# C: Citigroup’s Pharma Inducement Grants Spark Opportunity! **Overview:** Citigroup Inc.
Read more# POOL: Down 39%, But $281 Target Could Spark Gains!
Read more# DAWN: Stock Soars 66% on $2.5B Acquisition News! ## Acquisition Overview and Stock Surge Day One Biopharmaceuticals, Inc.
Read more# Citigroup, Inc. Gains from NewAmsterdam Pharma Inducement! ## Introduction: Capitalizing on Market Opportunities Citigroup Inc.
Read more# CEG: Analysts Slash Price Targets—What’s Next?
Read more# XENE: Major Phase 3 Results Coming March 9, 2026! ## Company Overview & Upcoming Catalyst **Xenon Pharmaceuticals Inc. (NASDAQ: XENE)** is a clinical-stage biopharmaceutical…
Read more# **DAWN: 66% Surge Post $2.5B Acquisition by Servier!** ## **Overview of Day One (DAWN) and the Servier Deal** Day One Biopharmaceuticals (NASDAQ: **DAWN**) is a clinical-stage…
Read more# MREO: Act Now—Secure Counsel Before Class Action Deadline! ## Company Overview and Recent Developments Mereo BioPharma Group plc (NASDAQ: MREO) is a UK-based clinical-stage…
Read more